1
/
of
1
Elabscience
SKU:PKSV030375
Recombinant SARS-CoV-2 Spike S1+S2 ECD (L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I)(His Tag )
Recombinant SARS-CoV-2 Spike S1+S2 ECD (L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I)(His Tag )
Regular price
$1,105.00 USD
Regular price
Sale price
$1,105.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant SARS-CoV-2 Spike S1+S2 ECD (ΔHV69-70, D614G, D796H)(His Tag), a cutting-edge product designed to facilitate comprehensive research and analysis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This recombinant protein, meticulously engineered with the utmost precision, offers an invaluable tool for scientists and researchers in their pursuit of understanding the intricate mechanisms and characteristics of this viral strain.
The SARS-CoV-2 Spike S1+S2 ECD (ΔHV69-70, D614G, D796H)(His Tag) boasts a highly purified composition, ensuring optimal quality and reliability in experimental settings. Its strategic modification, including the deletion of HV69-70, the D614G substitution, and the D796H mutation, enables enhanced stability and infectivity, rendering it an ideal candidate for various investigative applications.
This product is equipped with a His Tag, facilitating straightforward purification and detection processes, thereby streamlining experimental workflows and expediting research outcomes. The inclusion of this tag further enhances the versatility and compatibility of the recombinant protein, allowing for seamless integration into a wide range of experimental methodologies.
The Recombinant SARS-CoV-2 Spike S1+S2 ECD (ΔHV69-70, D614G, D796H)(His Tag) is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures to ensure utmost purity, consistency, and reproducibility. Each batch undergoes rigorous testing to guarantee its integrity and functionality, providing researchers with the utmost confidence in their experimental results.
With its unrivaled quality, strategic modifications, and user-friendly features, the Recombinant SARS-CoV-2 Spike S1+S2 ECD (ΔHV69-70, D614G, D796H)(His Tag) stands as an indispensable asset for scientists and researchers dedicated to unraveling the mysteries surrounding SARS-CoV-2. Empower your research endeavors with this exceptional tool, and pave the way for groundbreaking discoveries in the field of viral pathogenesis and vaccine development.
The SARS-CoV-2 Spike S1+S2 ECD (ΔHV69-70, D614G, D796H)(His Tag) boasts a highly purified composition, ensuring optimal quality and reliability in experimental settings. Its strategic modification, including the deletion of HV69-70, the D614G substitution, and the D796H mutation, enables enhanced stability and infectivity, rendering it an ideal candidate for various investigative applications.
This product is equipped with a His Tag, facilitating straightforward purification and detection processes, thereby streamlining experimental workflows and expediting research outcomes. The inclusion of this tag further enhances the versatility and compatibility of the recombinant protein, allowing for seamless integration into a wide range of experimental methodologies.
The Recombinant SARS-CoV-2 Spike S1+S2 ECD (ΔHV69-70, D614G, D796H)(His Tag) is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures to ensure utmost purity, consistency, and reproducibility. Each batch undergoes rigorous testing to guarantee its integrity and functionality, providing researchers with the utmost confidence in their experimental results.
With its unrivaled quality, strategic modifications, and user-friendly features, the Recombinant SARS-CoV-2 Spike S1+S2 ECD (ΔHV69-70, D614G, D796H)(His Tag) stands as an indispensable asset for scientists and researchers dedicated to unraveling the mysteries surrounding SARS-CoV-2. Empower your research endeavors with this exceptional tool, and pave the way for groundbreaking discoveries in the field of viral pathogenesis and vaccine development.
Share
